Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cirrhosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cirrhosis
    TopAbstracts in Cirrhosis 07/01/2008 - (DGNews)
    TopAbstracts in Cirrhosis 06/03/2008 - (DGNews)
    TopAbstracts in Cirrhosis 05/06/2008 - (DGNews)
    Sorafenib Safe in Patients With Unresectable Hepatocellular Carcinoma and Advanced Liver Cirrhosis: Presented at EASL - (DGDispatch)
    Peg-Interferon Improves Event-Free Survival Compared With Colchicine in Patients With Cirrhosis and Portal Hypertension: Presented at EASL - (DGDispatch)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases - Cirrhosis
        Tuberculous Peritonitis in a German Patient with Primary Biliary Cirrhosis: A Case Report
        Hematochezia in a Patient With Liver Cirrhosis
        Successful Outcome of a Pregnancy in Women with Advanced Cirrhosis Due to Hepatitis B Surface Antigenemia, Delta Super-Infection and Hepatitis C Co-Infection: A Case Report
        Phosphodiesterase 5 Inhibitors Lower Both Portal and Pulmonary Pressure in Portopulmonary Hypertension. A Case Report
        Invasive Pulmonary Aspergillosis in Patients with Decompensated Cirrhosis: Case Series

        Cases archive
          




        my personal edition > cirrhosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Misoprostol Briefly Counters Ibuprofen-Induced Renal Dysfunction in Cirrhotics

        A DGReview of :"Effect of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis: results of a double-blind placebo-controlled parallel group study"
        American Journal of Gastroenterology

        08/20/2002
        By David Loshak


        Ibuprofen causes renal dysfunction in decompensated cirrhotics but misoprostol may have some protective renal effects.

        Yet, these are "short-lived and clinically insignificant," say researchers at the University of Virginia Health and Science Center, Charlottesville, Virginia and Hadassah University Hospital, Jerusalem, Israel. And because of side effects, misoprostol should be used "with caution" in patients with cirrhosis, they advise.

        Noting that these patients are prone to develop renal failure when given nonsteroidal anti-inflammatory drugs, the researchers carried out a study to determine the safety and efficacy of misoprostol 400 micrograms in two repeated doses for the prevention of ibuprofen-induced renal function decrements in decompensated cirrhotics.

        Patients were given ibuprofen 800 mg with either misoprostol (n = 9) or placebo (n = 10) and another dose one hour later. The researchers assessed renal function tests by clearance techniques.

        Ibuprofen with placebo caused significant decreases in urinary output, insulin clearance, sodium excretion, osmolar clearance, free water clearance and urinary prostaglandin E2 excretion.

        Ibuprofen with the first misoprostol dose maintained urinary output and sodium excretion and caused free water clearance to increase. These changes lasted only one hour. The second misoprostol dose temporarily improved insulin and creatinine clearances.

        Half the patients who received misoprostol suffered from chills, fever and diarrhoea.
        American Journal of Gastroenterology 2002; 97(8):2033-2039. "Effect of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis: results of a double-blind placebo-controlled parallel group study"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send